By Dean Seal
Caribou Biosciences has hired Sri Ryali, the former chief financial officer of Codexis, to lead its finances.
The genome-editing biopharmaceutical company said Thursday that Ryali has been tapped to succeed Jason O'Byrne, who resigned as CFO in September to become the financial chief for Vir Biotechnology.
Before Codexis, Ryali was the CFO of Eiger BioPharmaceuticals and previously held roles at Aimmune Therapeutics, Onyx Pharmaceuticals and Amgen.
Write to Dean Seal at dean.seal@wsj.com
(END) Dow Jones Newswires
January 02, 2025 08:29 ET (13:29 GMT)
Copyright (c) 2025 Dow Jones & Company, Inc.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.